Simplex Trading’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$313K Buy
12,558
+11,656
+1,292% +$303K ﹤0.01% 4119
2026
Q2
$28.2K Sell
902
-154
-15% -$3.81K ﹤0.01% 6813
2026
Q1
$22.1K Buy
+1,056
New +$14.7K ﹤0.01% 6697
2025
Q3
– Sell
-49,901
Closed -$338K – 10079
2025
Q2
$255K Buy
+49,901
New +$123K ﹤0.01% 4245
2024
Q4
– Sell
-287
Closed -$1.33K – 9625
2024
Q3
$2K Buy
+287
New +$2.74K ﹤0.01% 8081
2024
Q1
– Sell
-170
Closed -$1K – 9890
2023
Q4
$1K Buy
+170
New +$1.48K ﹤0.01% 8588

Other funds holding TNGX

Simplex Trading's TNGX Position: Q3 2026 in Review

Simplex Trading increased its Tango Therapeutics (TNGX) stake by 1,292% in Q3 2026, buying an estimated $303K and bringing the position to 12,558 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #4119.

Simplex Trading first reported a position in TNGX in Q4 2023 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

  • Simplex Trading held 12,558 shares of Tango Therapeutics worth $313K as of Q3 2026.
  • Simplex Trading bought 11,656 Tango Therapeutics shares in Q3 2026, an estimated $303K.
  • Tango Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #4119 holding.
  • Simplex Trading first reported a position in Tango Therapeutics in Q4 2023 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.